|
1
|
Gilead Sciences
Foster City,
California
|
$125M
|
–
|
–
|
–
|
|
|
2
|
Farallon Capital Management
San Francisco,
California
|
$34.1M
|
–
|
–
|
–
|
|
|
3
|
RA Capital Management
Boston,
Massachusetts
|
$28.3M
|
–
|
–
|
–
|
|
|
4
|
Commodore Capital
New York
|
$27.8M
|
–
|
–
|
–
|
|
|
5
|
Janus Henderson Group
London,
|
$23.5M
|
+$325K
|
+11,384
|
+1%
|
|
|
6
|
Paradigm Biocapital Advisors
New York
|
$18.5M
|
–
|
–
|
–
|
|
|
7
|
Vanguard Capital Management
Malvern,
Pennsylvania
|
$13.6M
|
+$14M
|
+490,447
|
New
|
|
|
8
|
Parkman Healthcare Partners
Stamford,
Connecticut
|
$11.4M
|
+$4.62M
|
+161,870
|
+65%
|
|
|
9
|
Point72 Asset Management
Stamford,
Connecticut
|
$9.5M
|
-$7.32M
|
-256,504
|
-43%
|
|
|
10
|
|
$8.24M
|
-$625K
|
-21,899
|
-7%
|
|
|
11
|
Millennium Management
New York
|
$6.48M
|
+$3.86M
|
+135,429
|
+138%
|
|
|
12
|
|
$5.63M
|
+$298K
|
+10,447
|
+5%
|
|
|
13
|
Stempoint Capital
New York
|
$5.15M
|
+$819K
|
+28,707
|
+18%
|
|
|
14
|
B Group Inc
Dallas,
Texas
|
$4.88M
|
–
|
–
|
–
|
|
|
15
|
Marshall Wace
London,
United Kingdom
|
$4.53M
|
+$979K
|
+34,325
|
+27%
|
|
|
16
|
Adage Capital Partners
Boston,
Massachusetts
|
$4.47M
|
–
|
–
|
–
|
|
|
17
|
Patient Square Capital
Menlo Park,
California
|
$3.78M
|
+$266K
|
+9,315
|
+7%
|
|
|
18
|
Geode Capital Management
Boston,
Massachusetts
|
$3.69M
|
+$47.5K
|
+1,664
|
+1%
|
|
|
19
|
Schonfeld Strategic Advisors
New York
|
$3.34M
|
+$1.89M
|
+66,265
|
+122%
|
|
|
20
|
Caption Management
Oklahoma City,
Oklahoma
|
$2.27M
|
-$706K
|
-24,750
|
-23%
|
|
|
21
|
HighVista Strategies
Boston,
Massachusetts
|
$2.07M
|
+$2.13M
|
+74,735
|
New
|
|
|
22
|
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
$1.99M
|
+$2.04M
|
+71,606
|
New
|
|
|
23
|
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$1.92M
|
+$772K
|
+27,071
|
+64%
|
|
|
24
|
State Street
Boston,
Massachusetts
|
$1.57M
|
+$106K
|
+3,700
|
+7%
|
|
|
25
|
Seven Fleet Capital Management
Mountain View,
California
|
$1.56M
|
-$502K
|
-17,615
|
-24%
|
|
